Altria Group Inc. Chief Executive Marty Barrington is retiring and will be replaced by another 25-year company veteran. Mr. Barrington, who has held the top post for six years, will retire in May after a quarter of a century with the tobacco company, Altria said Thursday. His replacement is Howard Willard, 54, the company's current operating chief and former finance chief.
ApidraÂ® (insulin glulisine) is a prescription form of insulin used to treat type 1 diabetes and type 2 diabetes in adults. It is a rapid-acting insulin used to help control the spike in blood sugar levels that occurs after meals. It is typically used in combination with a long-acting insulin.
Humalog is a short-acting type of insulin. Insulin helps to control blood sugar levels in diabetes mellitus, including diabetes type 1 and diabetes type 2. Humalog is more popular than other insulins. There are currently no generic options for any insulin brand, but less expensive biosimilar versions may be available in the future.